TherapeuticsMD (TXMD) Cash from Investing Activities Growth (1y) (2012 - 2022)
TherapeuticsMD (TXMD) Cash from Investing Activities Growth (1y) (2012 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 13.93% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 57.14% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -186.78% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 551.55% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 526.11% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -3,664.79% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -3.45% |
| 10 | TherapeuticsMD | 280,418.39 | -8.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 95.11% |
| Sep 30, 2022 | 103.85% |
| Jun 30, 2022 | 14.61% |
| Mar 31, 2022 | 51.60% |
| Dec 31, 2021 | -206.48% |
| Sep 30, 2021 | 30.53% |
| Jun 30, 2021 | 77.69% |
| Mar 31, 2021 | 1.13% |
| Dec 31, 2020 | 97.62% |
| Sep 30, 2020 | 79.88% |
| Jun 30, 2020 | 67.03% |
| Mar 31, 2020 | 33.47% |
| Dec 31, 2019 | -2,986.19% |
| Sep 30, 2019 | 93.60% |
| Jun 30, 2019 | -288.71% |
| Mar 31, 2019 | -268.87% |
| Dec 31, 2018 | -90.95% |
| Sep 30, 2018 | -28,077.04% |
| Jun 30, 2018 | -16.12% |
| Mar 31, 2018 | -33.41% |